Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT03742037

Public ClinicalTrials.gov record NCT03742037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Subjects With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT03742037
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Viatris Innovation GmbH
Industry
Enrollment
427 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2018 (Actual)
Primary completion
Aug 31, 2021 (Actual)
Completion
Aug 25, 2022 (Actual)
Last update posted
Jul 29, 2026

2018 – 2022

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
University of California San Diego La Jolla California 92037-0493 —
Valerius Medical Group and Research Center Los Alamitos California 90720-5403 —
University of Colorado School of Medicine Aurora Colorado 80045 —
Robert W Levin MD PA Clearwater Florida 33765 —
Center for Rheumatology Immunology and Arthritis Fort Lauderdale Florida 33309 —
Life Clinical Trials Margate Florida 33063 —
D&H National Research Centers INC Miami Florida 33155 —
San Marcus Research Clinic Miami Lakes Florida 33014 —
Millennium Research Ormond Beach Florida 32174-1139 —
Integral Rheumatology & Immunology Specialists Plantation Florida 33324 —
Advanced Research Institute Inc Allergy & Rheumatology St. Petersburg Florida 33708 —
Axiom Clinical Research of Florida Tampa Florida 33603 —
North Georgia Rheumatology Group - Duluth Lawrenceville Georgia 30046 —
Institute of Arthritis Research Idaho Falls Idaho 83404 —
Washington University School of Medicine St Louis Missouri 63110 —
Innovative Health Research Las Vegas Nevada 89128 —
New York Presbyterian Columbia University Medical Center New York New York 10032 —
State University of New York Upstate Medical University Syracuse New York 13210 —
Joint Muscle Medical Care and Research Institute - Lilington Office Charlotte North Carolina 28204 —
DJL Clinical Research Charlotte North Carolina 28210 —
Paramount Medical Research and Consulting Middleburg Heights Ohio 44130 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Office of Ramesh C. Gupta, MD Memphis Tennessee 38119 —
Amarillo Center for Clinical Research Amarillo Texas 79124 —
Accurate Clinical Research Houston Texas 77034 —
Southwest Rheumatology Research, LLC Mesquite Texas 75150 —
Sun Research Institute San Antonio Texas 78215 —
Accurate Clinical Management Stafford Texas 77477 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03742037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03742037 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →